We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stericycle's (SRCL) Debt Woes Stay Amid Focus on Transformation
Read MoreHide Full Article
Stericycle, Inc. (SRCL - Free Report) has a comprehensive multiyear Business Transformation initiative in place, focused on enhancing long-term operational and financial performance. However, a debt-laden balance sheet remains a concern for the company.
Stericycle recently reported mixed fourth-quarter 2020 results, with earnings missing the Zacks Consensus Estimate and revenues surpassing the same. Adjusted earnings per share of 59 cents missed the Zacks Consensus Estimate by 7.8% and declined 18.1% year over year. Revenues of $655.9 million surpassed the consensus mark by 1.5% but declined 18% year over year.
The company’s shares have gained 26% over the past year, outperforming the 1.3% rally of the industry it belongs to.
Stericycle's cash and cash equivalent balance of $53.3 million at the end of the fourth quarter was well below the long-term debt level of $1.69 billion, underscoring that the company does not have enough cash to meet this debt burden. Also, the cash level cannot meet the short-term debt of $91 million.
The company’s Communication and Related Services (“CRS”) business have been weak for quite some time, weighing on its top line. The CRS business is witnessing lower revenues due to decline in recall events and lower call volumes in communication solutions. Revenues fell 43% year over year to $33.6 million in fourth-quarter 2020.
Nevertheless, Stericycle is progressing well with its comprehensive multi-year Business Transformation initiative aimed at improving long-term operational and financial performance. Key focus areas of the program include improving quality of revenue, driving operational efficiency through work measurement, asset optimization, technology, strategic sourcing, portfolio rationalization through divestitures, debt reduction and leverage improvement, and ERP implementation.
Zacks Rank and Stocks to Consider
Stericycle currently carries a Zacks Rank #4 (Sell).
The long-term expected earnings per share (three to five years) growth rate for Interpublic, Cross Country Healthcare and Charles River is pegged at 2.4%, 12% and 13%, respectively.
Zacks Top 10 Stocks for 2021
In addition to the stocks discussed above, would you like to know about our 10 best buy-and-hold tickers for the entirety of 2021?
Last year's 2020Zacks Top 10 Stocks portfolio returned gains as high as +386.8%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Image: Bigstock
Stericycle's (SRCL) Debt Woes Stay Amid Focus on Transformation
Stericycle, Inc. (SRCL - Free Report) has a comprehensive multiyear Business Transformation initiative in place, focused on enhancing long-term operational and financial performance. However, a debt-laden balance sheet remains a concern for the company.
Stericycle recently reported mixed fourth-quarter 2020 results, with earnings missing the Zacks Consensus Estimate and revenues surpassing the same. Adjusted earnings per share of 59 cents missed the Zacks Consensus Estimate by 7.8% and declined 18.1% year over year. Revenues of $655.9 million surpassed the consensus mark by 1.5% but declined 18% year over year.
The company’s shares have gained 26% over the past year, outperforming the 1.3% rally of the industry it belongs to.
Stericycle's cash and cash equivalent balance of $53.3 million at the end of the fourth quarter was well below the long-term debt level of $1.69 billion, underscoring that the company does not have enough cash to meet this debt burden. Also, the cash level cannot meet the short-term debt of $91 million.
The company’s Communication and Related Services (“CRS”) business have been weak for quite some time, weighing on its top line. The CRS business is witnessing lower revenues due to decline in recall events and lower call volumes in communication solutions. Revenues fell 43% year over year to $33.6 million in fourth-quarter 2020.
Nevertheless, Stericycle is progressing well with its comprehensive multi-year Business Transformation initiative aimed at improving long-term operational and financial performance. Key focus areas of the program include improving quality of revenue, driving operational efficiency through work measurement, asset optimization, technology, strategic sourcing, portfolio rationalization through divestitures, debt reduction and leverage improvement, and ERP implementation.
Zacks Rank and Stocks to Consider
Stericycle currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the broader Zacks Business Services sector are The Interpublic Group of Companies (IPG - Free Report) , Cross Country Healthcare (CCRN - Free Report) and Charles River Associates (CRAI - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The long-term expected earnings per share (three to five years) growth rate for Interpublic, Cross Country Healthcare and Charles River is pegged at 2.4%, 12% and 13%, respectively.
Zacks Top 10 Stocks for 2021
In addition to the stocks discussed above, would you like to know about our 10 best buy-and-hold tickers for the entirety of 2021?
Last year's 2020Zacks Top 10 Stocks portfolio returned gains as high as +386.8%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
AccessZacks Top 10 Stocks for 2021 today >>